Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2014 by Dana-Farber Cancer Institute
Sponsor:
Collaborator:
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Danielle Margalit, MD, MPH, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01783587
First received: January 30, 2013
Last updated: December 19, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)